Inactive
U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Benefit-Risk Lead

Regulatory & Quality (Life Sciences)Posted on Sep 24
Full-timeNo salary listed

About the Job

Requirements

  • A bachelor's or master's degree in a relevant scientific discipline is required.
  • Substantial experience in pharmaceutical clinical development, medicine safety, benefit-risk assessment, safety writing, or risk management is required.
  • Experience leading complex safety outputs, regulatory submissions, and interactions with varied internal and external stakeholders is required.
  • Ability to interpret complex scientific evidence, make transparent decisions, and communicate clearly in written and spoken English is required.
  • Ability to work across multiple priorities, short timelines, and ambiguity while maintaining quality, integrity, and patient focus is required.
  • Experience guiding cross-functional teams is required.

Responsibilities

  • Own the benefit-risk assessment and risk management strategy for assigned medicines or indications throughout development and their lifecycle.
  • Analyse clinical, non-clinical, post-marketing, product quality, patient, and real-world data to identify and assess emerging risks.
  • Lead cross-functional benefit-risk discussions, clarify decisions, and communicate strategic insights to senior governance groups.
  • Design safety monitoring, evidence generation, and risk-minimisation approaches that protect patients and strengthen development decisions.
  • Plan, author, review, and approve high-quality safety and regulatory documents within agreed timelines and quality standards.
  • Coordinate team outputs, delegate activities where appropriate, and build effective collaboration across scientific and medical partners.

Desired Qualifications

  • A relevant advanced degree such as an MD or PhD is desirable.
  • People leadership, coaching, or mentoring experience is valuable where relevant.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs